Yang Ma
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 7
- Psoriasis: Treatment and Pathogenesis 3
- Rheumatology 10
- Rheumatoid Arthritis Research and Therapies 7
- Co-authors
- Michael R. Shurin (8 shared papers)Wei Wei (21 shared papers)Galina V. Shurin (5 shared papers)Galina V. Shurin (3 shared papers)Chenchen Han (18 shared papers)Yanling Guan (6 shared papers)Dmitriy W. Gutkin (2 shared papers)Yang Wang (4 shared papers)
- Journals
- PLoS ONE (4 papers)Scientific Reports (3 papers)Biochemical and Biophysical Research Communications (3 papers)Biomedicine & Pharmacotherapy (3 papers)Acta Pharmaceutica Sinica B (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yang Ma
56 papers receiving 2k citations
Peers
Comparison fields: 5 of 90
- Immunology 446
- Rheumatology 177
- Hepatology 110
- Oncology 269
- Complementary and alternative medicine 82
Countries citing papers authored by Yang Ma
This map shows the geographic impact of Yang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ma more than expected).
Fields of papers citing papers by Yang Ma
This network shows the impact of papers produced by Yang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ma. The network helps show where Yang Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 302 | |
| 2 | 2022 | 181 | |
| 3 | 2012 | 117 | |
| 4 | 2017 | 103 | |
| 5 | 2014 | 81 | |
| 6 | 2013 | 79 | |
| 7 | 2009 | 61 | |
| 8 | 2016 | 58 | |
| 9 | 2019 | 56 | |
| 10 | 2021 | 51 | |
| 11 | 2014 | 49 | |
| 12 | 2016 | 43 | |
| 13 | 2010 | 40 | |
| 14 | 2021 | 39 | |
| 15 | 2015 | 38 | |
| 16 | 2009 | 37 | |
| 17 | 2022 | 37 | |
| 18 | 2018 | 36 | |
| 19 | 2016 | 35 | |
| 20 | 2020 | 35 |
About Yang Ma
Yang Ma is a scholar working on Immunology, Rheumatology, Hepatology, Oncology and Complementary and alternative medicine, having authored 59 papers that have together received 2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Immunotherapy and Immune Responses (7 papers), Reproductive Biology and Fertility (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Receptor Mechanisms and Signaling (3 papers) and Inflammasome and immune disorders (3 papers). The work is most often cited by research in Immunology (446 citations), Rheumatology (177 citations), Hepatology (110 citations), Oncology (269 citations) and Complementary and alternative medicine (82 citations). Yang Ma has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Michael R. Shurin, Wei Wei, Galina V. Shurin, Galina V. Shurin, Chenchen Han, Yanling Guan, Dmitriy W. Gutkin, Yang Wang, Bo Liang and Marianna Agassandian. Their work appears in journals such as PLoS ONE, Scientific Reports, Biochemical and Biophysical Research Communications, Biomedicine & Pharmacotherapy and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.